NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/14/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization11,246 mln
Float155 mln
Earnings Date11/03/2026
EPS
1.16
Stretched
P / E
62.41
Richly valued
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.57
Likely reliable
1-Year Forecast
69.73
Fairly priced
Relative Strength
32
/ 100
Underperforming
Business Description
Founded in 1976 and based in Minneapolis, Minnesota, Bio-Techne develops and sells a broad range of tools and materials that support scientific research, medical testing, and the production of advanced therapies. Its products include proteins, antibodies, and laboratory instruments used by researchers and clinicians to study and measure biological activity. The company also produces diagnostic testing products and tissue analysis tools that help identify genetic conditions and cancer. Bio-Techne serves customers across the globe through two main business areas covering protein science and diagnostics.
